P53350 (PLK1_HUMAN) Homo sapiens (Human)

Serine/threonine-protein kinase PLK1 UniProtKBInterProSTRINGInteractive Modelling

603 aa; Sequence (Fasta)

Available Structures

70 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
CRYSTAL STRUCTURE OF WILD-TYPE PLK-1 KINASE DOMAIN IN COMPLEX WITH A SELECTIVE DARPIN Heteromer
39-323
Assess
Crystal structure of human Plk1-PBD in complex with WSSSLATPPTLSSpTVLI phosphopeptide from BRCA2 Heteromer
P51587;
370-593
GOL;
Assess
Polo-like kinase I Polo-box domain in complex with FMPPPMSpSM phosphopeptide from TCERG1 Heteromer
O14776;
372-594
1PE;PEG;PG0;
Assess
phospho-Pon binding-induced Plk1 dimerization Heteromer
O96561;
371-593
GOL;
Assess
Molecular and structural basis of polo-like kinase 1 substrate recognition: Implications in centros… Heteromer
P30307;
371-593
FMT;
Assess
Plk1 polo-box domain bound to HPV18 L2 residues 209-215 with pThr213 Heteromer
P06793;
373-594
Assess
Plk1 polo-box domain bound to HPV4 L2 residues 251-257 with pThr255 Heteromer
Q07862;
373-594
Assess
Molecular and structural basis of polo-like kinase 1 substrate recognition: Implications in centros… Heteromer
P30307;
373-594
Assess
PLK1 in complex with BI6727homo-2-mer37-329
IBI;EDO;ACT;PEG;ZN;GOL;
Assess
Crystal structure of Polo-like kinase 1 in complex with NMS-P937homo-2-mer39-329
937;ZN;TLA;
Assess
CRYSTAL STRUCTURE OF POLO-LIKE KINASE 1 IN COMPLEX WITH A 5-(2-AMINO- PYRIMIDIN-4-YL)-1H-PYRROLE IN…homo-2-mer39-329
ZN;TLA;939;
Assess
CRYSTAL STRUCTURE OF POLO-LIKE KINASE 1 IN COMPLEX WITH A 2-(2-AMINO- PYRIMIDIN-4-YL)-1,5,6,7-TETRA…homo-2-mer39-329
ZN;TLA;664;
Assess
Crystal structure of Polo-like kinase 1 in complex with a pyrazoloquinazoline inhibitorhomo-2-mer39-328
071;ZN;TLA;
Assess
Structure of PLK1 in complex with BI2536monomer37-330
ZN;R78;TLA;SRT;TAR;
Assess
Structure of the Catalytic Domain of Human Polo-like Kinase 1monomer37-330
ZN;ACT;626;
Assess
The Crystal Structure of PLK1 from Biortus.monomer37-330
ANP;ZN;ACT;PEG;EDO;
Assess
Crystal structure of PLK1 in complex with a novel 5,6-dihydroimidazolo[1,5-f]pteridine inhibitor.monomer37-330
79D;ZN;
Assess
Crystal structure of PLK1 in complex with a novel 5,6-dihydroimidazolo[1,5-f]pteridine inhibitormonomer37-330
ZN;79C;
Assess
Crystal structure of PLK1 in complex with a pyrimidodiazepinone inhibitormonomer38-330
1J3;ZN;ACT;
Assess
Crystal structure of PLK1 in complex with TAK-960monomer38-330
ZN;ACT;1J4;
Assess
Structure of human PLK1 in complex with 2-Allyl-1-[6-(1-hydroxy-1-methyl-ethyl)-pyridin-2-yl]-6-[4-…monomer39-330
ACT;8X7;ZN;
Assess
Structure of the Catalytic Domain of Human Polo-like Kinase 1monomer37-328
ZN;ACT;MG;ANP;
Assess
Structure of PLK1 kinase domain in complex with a benzolactam-derived inhibitormonomer42-328
ZN;3TA;
Assess
Structure of PLK1 in complex with peptidemonomer367-603
PO4;
Assess
Polo-like kinase 1 Polo box domain in complex with Ac-LHSpTA-NH2 peptidemonomer371-603
Assess
Crystal structure of Plk1 Polo-box domain in complex with PL-74monomer371-601
SO4;GOL;
Assess
Crystal structure of Plk1 Polo-box domain in complex with PL-2monomer372-599
10×EDO;
Assess
PLK-1 polo-box domain in complex with Bioactive Imidazolium-containing phosphopeptide macrocycle 4Cmonomer372-597
Assess
The Crystal Structure of polo-box domain of PLK1 from Biortus.monomer371-595
EDO;
Assess
PLK-1 polo-box domain in complex with Bioactive Imidazolium-containing phosphopeptide macrocycle 3Cmonomer372-595
Assess
Structure of human Plk1 PBD in complex with Allopole-Amonomer371-594
GOL;VIH;
Assess
Unliganded form of Polo-like kinase I Polo-box domainmonomer371-594
SO4;GOL;
Assess
Structure of human Plk1-PBD in complex with PLHSpTmonomer371-594
GOL;EDO;
Assess
The structure of the polo-box domain (PBD) of Plk1 in complex with Z228588490monomer371-594
Z24;
Assess
human Plk1-PBD with a glycerol bound at the phophopeptide binding sitemonomer371-594
Assess
The polo-box domain of Plk1 in complex with a phospho-peptidemonomer371-594
Assess
Polo-like kinase I Polo-box domain in complex with FDPPLHSpTA phosphopeptide from PBIP1monomer371-594
GOL;
Assess
The structure of the polo-box domain (PBD) of polo-like kinase 1 (Plk1) in complex with JES107monomer371-594
8VB;
Assess
Human Plk1-PBD in complex with Thymoquinone at the phophopeptide binding sitemonomer371-594
Assess
Plk-1 polo-box domain in complex with histidine N(tau)-cyclized Macrocycle 5b.monomer373-595
AML;
Assess
Polo-like kinase I Polo-box domain in complex with DPPLHSpTA phosphopeptide from PBIP1monomer372-594
GOL;PO4;
Assess
Structure of human Plk1-PBD with glycerol and sulfate in the phophopeptide binding sitemonomer371-593
SO4;GOL;EDO;
Assess
The structure of the polo-box domain (PBD) of polo-like kinase 1 (Plk1) in complex with LDPPLHSpTA …monomer372-594
PG0;GOL;
Assess
The structure of the polo-box domain (PBD) of polo-like kinase 1 (Plk1)monomer371-593
Assess
Polo-like kinase I Polo-box domain in complex with PLHSpTA phosphopeptide from PBIP1monomer371-593
GOL;
Assess
The structure of the polo-box domain (PBD) of polo-like kinase 1 (Plk1) in complex with LHSpTA pept…monomer373-595
Assess
Structure of a human Plk1 Polo-box domain/phosphopeptide complexmonomer373-595
Assess
Molecular and structural basis of Plk1 substrate recognition: Implications in centrosomal localizat…monomer371-593
Assess
The structure of the polo-box domain (PBD) of polo-like kinase 1 (Plk1) in complex with Alpha-Bromo…monomer371-593
8Z5;
Assess
Crystal structure of Plk1 Polo-box domain in complex with PL-42monomer373-595
Assess
The structure of the polo-box domain (PBD) of Plk1 in complex with Alpha-Bromo-3-Iodotoluene.monomer371-593
8Z5;
Assess
Polo-like kinase I Polo-box domain in complex with MQSpSPL phosphopeptidemonomer372-594
GOL;
Assess
Crystal structure of Plk1 Polo-box domain in complex with PL-49monomer371-593
CXS;PO4;
Assess
Polo-like kinase I Polo-box domain in complex with MQSpTPL phosphopeptidemonomer371-592
SO4;GOL;
Assess
Peptide-Based Inhibitors of Plk1 Polo-box Domainmonomer373-594
Assess
Polo-like kinase 1 Polo box domain in complex with a C6H5(CH2)8-derivatized peptide inhibitormonomer373-594
Assess
Crystal structure of Plk1 Polo-box domain in complex with PL-55monomer372-593
ADM;
Assess
PLK-1 polo-box domain in complex with a high affinity macrocycle synthesized using a novel glutamic…monomer372-593
ZOY;
Assess
Crystal structure of polo-like kinase(PLK1)PBD in complex with phospho peptidemonomer373-594
Assess
Human Plk1-PBD in complex with Poloxime ((E)-4-(hydroxyimino)-2-isopropyl-5-methylcyclohexa-2,5-die…monomer372-593
Assess
The structure of the polo box domain of human Plk1monomer372-593
Assess
A New Class of Peptidomimetics Targeting the Polo-box Domain of Polo-like kinase 1monomer371-592
Assess
The structure of the polo-box domain (PBD) of polo-like kinase 1 (Plk1) in complex with 3-(1-benzot…monomer373-594
GOL;
Assess
Oxime-based Post Solid-phase Peptide Diversification: Identification of High Affinity Polo-like Kin…monomer373-593
CL;
Assess
The structure of the polo-box domain (PBD) of polo-like kinase 1 (Plk1) in complex with hydrocinnam…monomer374-594
Assess
Polo-like kinase 1 Polo box domain in complex with PPHSpT peptidemonomer373-593
Assess
PLK-1 polo-box domain in complex with Bioactive Imidazolium-containing phosphopeptide macrocycle 3Bmonomer373-592
Assess
A New Class of Peptidomimetics Targeting the Polo-box Domain of Polo-like kinase 1monomer373-592
Assess
Crystal Structure of Polo Box Domain in Complex with Cyclic Peptide Inhibitormonomer373-592
Assess
A New Class of Peptidomimetics Targeting the Polo-box Domain of Polo-like kinase 1monomer373-592
SO4;
Assess

2 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
1q4k.2.Amonomer0.87372-593
MET;100.00
Assess
5ta6.1.Amonomer0.8437-330
79D;99.68
Assess